43 In an obesity-centered cohort in the US, 54% of patients discontinued their GLP-1 RA within 1 year, and 72% discontinued within 2 years
This dual action on blood sugar control and appetite suppression makes GLP-1 an essential player in maintaining metabolic balance
This article briefly summarizes the evidence, benefits, limitations, and potential best candidates for GLP-1 agonist treatment for alcohol use problems, considering both harm reduction (moderate, safer drinking) and abstinence goals
These medications mimic the GLP-1 hormone naturally produced in the human body, and the researchers will examine how they affect factors such as body weight, body composition, balance and fall risk, substance use, quality of life and health care utilization
KISSEI PHARMACEUTICAL), and Subsidies or Donations (ONO PHARMACEUTICAL
Evaluate whether they mandate baseline cardiovascular assessment (EKG or echocardiogram if indicated), assess family history of medullary thyroid cancer or multiple endocrine neoplasia type 2, and perform thyroid function testing
